BIO vs ECBK · rev $2.58B vs P/E 28, $146.2M cap
BIO (BIO) versus ECB Bancorp Inc. (ECBK) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
ECB Bancorp Inc. (ECBK) is a banks - regional company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
ECBK does not have a complete income-statement cache yet.
BIO currently screens at market cap $0. ECBK currently screens at market cap $146.2M and trailing P/E 28.4.
Not investment advice. Open the BIO and ECBK stock pages for the full models.
Not investment advice.